Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Angela Scheuerle

Pediatrics Dallas, TX Medical Doctor

NPI 1073570586 CMS profile 320386

5323 Harry Hines Blvd, Dallas, TX 75390

Open in the dashboard

General payments

$117,518

685 records reported · program years 2019–2025

Research payments

$80,903

Paid to them · 410 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$14,866 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Angela Scheuerle of Dallas, TX is reported in the CMS Open Payments database as having received $117,518 across 685 general payments and $80,903 in research payments paid to them. Separately, studies naming them as principal investigator received $14,866 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,922 78
2025 Research $3,417 70
2024 General $29,910 86
2024 Research $5,163 71
2023 General $11,114 101
2023 Research $7,341 74
2022 General $12,508 67
2022 Research $5,099 56
2021 General $20,730 81
2021 Research $12,511 55
2020 General $16,805 98
2020 Research $12,848 21
2019 General $14,529 174
2019 Research $34,525 63

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Angela Scheuerle
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Angela Scheuerle were reported at $11,922. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Angela Scheuerle Pediatrics median Middle half National median
2019 $14,529 $86 $31–$183 $163
2020 $16,805 $49 $22–$110 $114
2021 $20,730 $68 $27–$158 $132
2022 $12,508 $77 $30–$173 $149
2023 $11,114 $88 $33–$190 $160
2024 $29,910 $94 $34–$206 $164
2025 $11,922 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ucb SA $56,250 70 payments
  2. AbbVie, Inc. $22,247 104 payments
  3. UCB Biosciences Inc. $6,125 6 payments
  4. ViiV Healthcare Company $5,837 49 payments
  5. Merck Sharp & Dohme Corporation $5,691 100 payments
  6. Hikma Pharmaceuticals USA $4,381 73 payments
  7. Boehringer Ingelheim Pharmaceuticals, Inc. $4,270 80 payments
  8. Amneal Pharmaceuticals LLC $3,889 59 payments
  9. Sanofi US Services Inc. $2,178 2 payments
  10. Sandoz Inc. $1,944 42 payments
  11. Other $4,707 100 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $113,522 553 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,846 32 payments
  3. Travel and Lodging $861 38 payments
  4. Grant $718 7 payments
  5. Food and Beverage $570 55 payments
Products named General payments · program years 2019–2025
  1. NORVIR $19,667 81 payments
  2. Zidovudine $3,391 49 payments
  3. TIVICAY $3,250 5 payments
  4. PIFELTRO $2,223 39 payments
  5. ISENTRESS $2,223 39 payments
  6. DELSTRIGO $2,223 39 payments
  7. NEVIRAPINE $1,944 42 payments
  8. CRIXIVAN $1,695 27 payments
  9. Abacavir Sulfate $1,438 34 payments
  10. AUBAGIO $1,089 1 payment
  11. Other $5,662 90 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Lupin Inc. $30,435 73 payments
  2. Novo Nordisk AS $16,925 10 payments
  3. Teva Pharmaceuticals USA, Inc. $5,617 98 payments
  4. UCB, Inc. $4,760 7 payments
  5. Mylan Inc. $4,090 65 payments
  6. F. Hoffmann-La Roche AG $4,052 4 payments
  7. E.R. Squibb & Sons, L.L.C. $4,025 8 payments
  8. Apotex Inc. $2,852 44 payments
  9. Celltrion, Inc. $2,812 4 payments
  10. Dr.Reddy's Laboratories,Inc. $1,492 26 payments

Records

1,095 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record